Gold futures were sharply lower Friday, settling at their lowest in two months and losing nearly 4% for the week. A surprise monthly climb in U.S. jobs and a drop in the nation's unemployment rate led to a rally in the stock market, dulling demand for haven gold.
August gold lost $44.40, or 2.6%, to settle at $1,683 an ounce. That was the lowest finish for a most-active contract since April 3. For the week, prices lost 3.9%, according to FactSet data.
Source: Marketwatch

Gold futures fell on Friday morning, amid a global rally in stocks that was dulling the appeal for the yellow metal.
August gold on Comex shed $18.70, or 1.1%, at $1,708.70 an ounce, nearly giving up all of its gains from the previous session.
Meanwhile, July silver lost 24 cents, or 1.3%, at $17.830 an ounce, after sinking 0.6% on Thursday.
For the week, gold is down 2.5%, while silver has lost 3.6% over the past five trading sessions.
Source : Marketwatch

U.S. stocks jumped at the open on Friday after a closely watched report showed a surprise drop in the U.S. unemployment rate, lending weight to hopes of a faster economic rebound from a coronavirus-driven slump.
The Dow Jones Industrial Average rose 554.98 points, or 2.11%, at the open to 26,836.80. The S&P 500 opened higher by 51.49 points, or 1.65%, at 3,163.84, while the Nasdaq Composite gained 87.73 points, or 0.91%, to 9,703.54 at the opening bell.
Source : Reuters

Wall Street surged on Friday after a strikingly upbeat May jobs report unexpectedly provided the clearest evidence yet that the U.S. economy is headed for a quicker-than-anticipated recovery.
The Nasdaq breached its all-time closing high reached in February but pared its gains to end the session just below it. All three major U.S. stock indexes advanced two percent or more.
Unofficially, the Dow Jones Industrial Average rose 829.16 points, or 3.15%, to 27,110.98, the S&P 500 gained 81.58...

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that's been widely questioned by other scientists.
Thursday's retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.
The study leaders also...

Japan's Nikkei was little changed on Friday morning as investors kept to the sidelines before the release of a key U.S. jobs report, while oil and mining shares underperformed after oil prices fell on global growth concerns.

The Nikkei share average was flat at 21,696.57 in midmorning trade. For the week, the index has gained 2% after a Sino-U.S. trade truce sparked hopes the two warring sides could make progress in long-drawn out negotiations.

Investors are waiting on the U.S. jobs report due out later in the day, which could determine if the Federal Reserve cuts rates later this month or delays such a move to its next meeting.

Hong Kong stocks ended the week on a strong note Friday, marking a fifth straight advance as early profit-taking gave way to optimism over the worldwide easing of lockdown measures and hopes for the g...

Wall Street surged on Friday after a strikingly upbeat May jobs report unexpectedly provided the clearest evidence yet that the U.S. economy is headed for a quicker-than-anticipated recovery.
The Nas...

European stocks racked up their best week in two months on Friday, with investors scooping up battered shares of banks, automakers and travel companies amid growing signs that the pandemic-hit global ...

Stocks rallied on Friday after a historic and surprising gain in U.S. jobs raised hope the economy is starting to recover from the coronavirus pandemic.
The Dow Jones Industrial Average jumped 1,030 ...

U.S. stocks jumped at the open on Friday after a closely watched report showed a surprise drop in the U.S. unemployment rate, lending weight to hopes of a faster economic rebound from a coronavirus-dr...

Gold futures were sharply lower Friday, settling at their lowest in two months and losing nearly 4% for the week. A surprise monthly climb in U.S. jobs and a drop in the nation's unemployment rate led to a rally in the stock market, dulling demand for haven gold.
August gold lost $44.40, or 2.6%, to settle at $1,683 an ounce. That was the lowest finish for a most-active contract since April 3. For the week, prices lost 3.9%, according to FactSet data.
Source: Marketwatch

Gold futures fell on Friday morning, amid a global rally in stocks that was dulling the appeal for the yellow metal.
August gold on Comex shed $18.70, or 1.1%, at $1,708.70 an ounce, nearly giving up all of its gains from the previous session.
Meanwhile, July silver lost 24 cents, or 1.3%, at $17.830 an ounce, after sinking 0.6% on Thursday.
For the week, gold is down 2.5%, while silver has lost 3.6% over the past five trading sessions.
Source : Marketwatch

U.S. stocks jumped at the open on Friday after a closely watched report showed a surprise drop in the U.S. unemployment rate, lending weight to hopes of a faster economic rebound from a coronavirus-driven slump.
The Dow Jones Industrial Average rose 554.98 points, or 2.11%, at the open to 26,836.80. The S&P 500 opened higher by 51.49 points, or 1.65%, at 3,163.84, while the Nasdaq Composite gained 87.73 points, or 0.91%, to 9,703.54 at the opening bell.
Source : Reuters

Wall Street surged on Friday after a strikingly upbeat May jobs report unexpectedly provided the clearest evidence yet that the U.S. economy is headed for a quicker-than-anticipated recovery.
The Nasdaq breached its all-time closing high reached in February but pared its gains to end the session just below it. All three major U.S. stock indexes advanced two percent or more.
Unofficially, the Dow Jones Industrial Average rose 829.16 points, or 3.15%, to 27,110.98, the S&P 500 gained 81.58...

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that's been widely questioned by other scientists.
Thursday's retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.
The study leaders also...